Molecular Mechanism of Anti-e Like Antibodies in RhDCCee Phenotypic Individuals.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Wu Chang-Lin, Cai Zhong-Ren, Li Guang-Qiu, Yi Pin, Ye Zhi-Shun, Shao Chaopeng
{"title":"Molecular Mechanism of Anti-e Like Antibodies in RhDCCee Phenotypic Individuals.","authors":"Wu Chang-Lin, Cai Zhong-Ren, Li Guang-Qiu, Yi Pin, Ye Zhi-Shun, Shao Chaopeng","doi":"10.7754/Clin.Lab.2025.250105","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The aim was to investigate the serotype characteristics and molecular mechanism of anti-e like antibody production in individuals with RhDCCee phenotype from a patient with PTR.</p><p><strong>Methods: </strong>ABO, RhD, and RhCcEe blood groups were identified by micro-column gel card, the irregular antibody screening and antibody specificity were identified by anti-human globulin assay. RHD and RHCE genes were typed by PCR-SSP, RHD/RHCE sequences were analyzed by first generation and third generation full-length sequencing.</p><p><strong>Results: </strong>ABO and Rh phenotypes were type O and RhDCCee. The irregular antibodies were positive and specific antibodies were anti-e. PCR results showed that RHD exons 1 - 10 were all positive, while RHCE exons 1, 3 - 10 were positive, exon 2 was negative. The first-generation sequencing of RHD/RHCE showed that RHD exons 1 - 10 were without mutations, RHCE exons 1 and 2 had common point mutations, no novel mutation point was found in exons 3 - 10. The full-length sequencing of RHD/RHCE showed that the new allele of RHD*01 could not be con-firmed, and a sequencing depth decrease was found in exon 3 region. The RHCE two haploids were all Ce and the alleles were RHCE*02 or RHCE*Ce. The mutation site of RHCE exons were the same as that of the first-generation sequencing; however, the three generations of full-length sequencing showed that the RHCE exon 2 and 3 were very low in sequencing depth and there might be structural variation.</p><p><strong>Conclusions: </strong>The molecular mechanism of anti-e like antibodies in RhDCCee phenotype individuals is not completely clear. Three generation full-length sequencing indicated that this phenomenon may be caused by structural variation of RHD/RHCE genomic.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 7","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2025.250105","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The aim was to investigate the serotype characteristics and molecular mechanism of anti-e like antibody production in individuals with RhDCCee phenotype from a patient with PTR.

Methods: ABO, RhD, and RhCcEe blood groups were identified by micro-column gel card, the irregular antibody screening and antibody specificity were identified by anti-human globulin assay. RHD and RHCE genes were typed by PCR-SSP, RHD/RHCE sequences were analyzed by first generation and third generation full-length sequencing.

Results: ABO and Rh phenotypes were type O and RhDCCee. The irregular antibodies were positive and specific antibodies were anti-e. PCR results showed that RHD exons 1 - 10 were all positive, while RHCE exons 1, 3 - 10 were positive, exon 2 was negative. The first-generation sequencing of RHD/RHCE showed that RHD exons 1 - 10 were without mutations, RHCE exons 1 and 2 had common point mutations, no novel mutation point was found in exons 3 - 10. The full-length sequencing of RHD/RHCE showed that the new allele of RHD*01 could not be con-firmed, and a sequencing depth decrease was found in exon 3 region. The RHCE two haploids were all Ce and the alleles were RHCE*02 or RHCE*Ce. The mutation site of RHCE exons were the same as that of the first-generation sequencing; however, the three generations of full-length sequencing showed that the RHCE exon 2 and 3 were very low in sequencing depth and there might be structural variation.

Conclusions: The molecular mechanism of anti-e like antibodies in RhDCCee phenotype individuals is not completely clear. Three generation full-length sequencing indicated that this phenomenon may be caused by structural variation of RHD/RHCE genomic.

抗e样抗体在RhDCCee表型个体中的分子机制。
背景:目的是研究PTR患者RhDCCee表型个体的血清型特征和抗e样抗体产生的分子机制。方法:采用微柱凝胶卡鉴定ABO、RhD、RhCcEe血型,采用抗人球蛋白法鉴定不规则抗体筛选及抗体特异性。采用PCR-SSP分型RHD和RHCE基因,采用第一代和第三代全序列测序分析RHD/RHCE基因序列。结果:ABO和Rh表型分别为O型和RhDCCee。不规则抗体阳性,特异性抗体为抗e。PCR结果显示,RHD外显子1 ~ 10均为阳性,而RHCE外显子1、3 ~ 10为阳性,外显子2为阴性。RHD/RHCE第一代测序结果显示,RHD外显子1 ~ 10无突变,RHCE外显子1和2有共同点突变,外显子3 ~ 10未发现新的突变点。RHD/RHCE的全长测序结果显示,RHD*01的新等位基因无法确认,且外显子3区测序深度下降。RHCE两个单倍体均为Ce,等位基因为RHCE*02或RHCE*Ce。RHCE外显子突变位点与第一代测序相同;但三代全长测序结果显示,RHCE外显子2和3的测序深度很低,可能存在结构变异。结论:抗e样抗体在RhDCCee表型个体中的分子机制尚不完全清楚。三代全基因组测序表明,这种现象可能是由RHD/RHCE基因组结构变异引起的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信